Page last updated: 2024-08-24

3-iodobenzylguanidine and Prodromal Characteristics

3-iodobenzylguanidine has been researched along with Prodromal Characteristics in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Arafuka, S; Fujishiro, H; Iritani, S; Iwamoto, K; Miyata, S; Ogasawara, K; Ozaki, N; Torii, Y1
Berg, D; Postuma, RB1

Reviews

1 review(s) available for 3-iodobenzylguanidine and Prodromal Characteristics

ArticleYear
Prodromal Parkinson's Disease: The Decade Past, the Decade to Come.
    Movement disorders : official journal of the Movement Disorder Society, 2019, Volume: 34, Issue:5

    Topics: 3-Iodobenzylguanidine; Anxiety; Biomarkers; Biopsy; Brain; Cognitive Dysfunction; Depression; Erectile Dysfunction; Female; Functional Neuroimaging; Humans; Hypotension, Orthostatic; Male; Neuroimaging; Olfaction Disorders; Parkinson Disease; Prodromal Symptoms; Radionuclide Imaging; Radiopharmaceuticals; REM Sleep Behavior Disorder; Risk Assessment; Sensitivity and Specificity; Sleepiness; Substantia Nigra; Urination Disorders

2019

Other Studies

1 other study(ies) available for 3-iodobenzylguanidine and Prodromal Characteristics

ArticleYear
Temporal trajectories of proposed biomarkers in psychiatric-onset prodromal dementia with Lewy bodies: a case report.
    Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society, 2023, Volume: 23, Issue:1

    Topics: 3-Iodobenzylguanidine; Biomarkers; Humans; Lewy Bodies; Lewy Body Disease; Prodromal Symptoms

2023